Contents
- Hero Section – Your Premium Source for Biotinylated ANP (1‑28) Peptide
- Problem Agitation – Why Researchers Struggle with Conventional Peptides
- Solution Presentation – What Sets Our Biotinylated ANP (1‑28) Apart
- Social Proof – Trusted by Leading Labs & Pharma Companies
- Frequently Asked Questions (FAQ)
- Strong Call‑to‑Action – Secure Your Supply Today
- Real User Reviews & Praise
- About the Author
Biotinylated ANP (1‑28) Peptide – High‑Purity, Fast‑Delivery Solution for Cardiovascular Research
Accelerate your drug‑discovery pipeline with a peptide that combines the biological potency of atrial natriuretic peptide (ANP) and the versatile affinity of biotin. Designed for **research managers**, **technical directors**, and **operations leaders** who demand consistent quality, transparent pricing, and on‑time delivery.
Get Free Quote in 24 hProblem Agitation – Why Researchers Struggle with Conventional Peptides
When you’re managing a high‑stakes cardiovascular project, **any delay or inconsistency in peptide supply can cost weeks of valuable bench time and millions of dollars**. Below are the three most common pain points we hear from corporate purchasing managers:
- High Price & Unpredictable Cost Structure – Many vendors quote “per‑gram” rates but hide extra fees for shipping, customs clearance, and quality‑control certificates. This makes budgeting a nightmare.
- Variable Purity & Inconsistent Bioactivity – A 95 % purity label on a supplier’s sheet often translates to 10‑15 % loss of activity after storage, forcing repeat orders.
- Slow Delivery & Expensive Freight – Typical lead times of 4‑6 weeks from China, coupled with high air‑freight charges, cause project timelines to slip.
According to a 2025 industry survey, **37 % of pharmaceutical R&D teams delayed their next‑phase trials because of peptide supply issues**. The data is clear: you need a partner that eliminates these risks.
Solution Presentation – What Sets Our Biotinylated ANP (1‑28) Apart
Core Advantages
- Powerful Factory & GMP‑Certified Production – Our Zhengzhou facility operates under GMP, ISO 9001, and FDA‑registered DMF, guaranteeing batch‑to‑batch consistency.
- Quality Assurance with Dual‑Verification – Each lot undergoes HPLC, LC‑MS, and functional bioassay; certificates of analysis (CoA) are provided in PDF and XML formats for easy import into LIMS.
- OEM/ODM Design Flexibility – Need a custom linker length or a different biotin orientation? Our in‑house peptide synthesis team can deliver tailored versions within 2 weeks.
- High‑Speed Delivery Network – We partner with DHL Express and FedEx International Priority; most US orders ship within 48 hours of payment, with real‑time tracking.
- Cost‑Effective Pricing Model – Transparent tiered pricing from 10 mg to 5 kg, no hidden customs fees, and volume discounts up to 30 %.
Technical Specifications
| Parameter | Our Product | Industry Avg. |
|---|---|---|
| Sequence | Biotin‑Lys‑ANP(1‑28) | Varies |
| Purity (HPLC) | ≥ 98 % | ≥ 95 % |
| Molecular Weight (Da) | 3325.8 ± 0.5 | ± 1.0 |
| Stability (–20 °C, 12 mo) | 95 % activity retained | ≈ 80 % |
| Form | Lyophilized powder, 10 mg‑5 kg | Lyophilized powder |
| Certificate | CoA, MS‑MS, FDA‑DMF, ISO 9001 | CoA only |
Application Scenarios & Case Studies
Our Biotinylated ANP (1‑28) peptide is engineered for **high‑affinity pull‑down assays, surface plasmon resonance (SPR), and ELISA development**. Below are three real‑world examples:
- Cardiovascular Receptor Mapping (USA, 2024) – A leading biotech used our peptide to map NPR‑A receptors in cultured cardiomyocytes, reducing assay time from 48 h to 24 h and cutting reagent costs by 28 %.
- High‑Throughput Screening Platform (Germany, 2023) – Integrated the biotinylated peptide into a 384‑well SPR array, achieving a Z′‑factor of 0.73, surpassing the industry benchmark of 0.5.
- GMP‑Compliant Clinical‑Grade Production (Japan, 2025) – Supplied 2 kg of GMP‑grade peptide for a Phase II trial, delivering on schedule with a zero‑defect rate.
Biotin-[Gln1]-Gastrin-I-(human)-product Anemia-and-Angiogenesis-research-peptide Biotin-Neurokinin-A-and-B AQP2-antibody-generation-peptide
Frequently Asked Questions (FAQ)
What is the minimum order quantity (MOQ) for Biotinylated ANP (1‑28) peptide?
The MOQ is **10 mg** for research‑grade material. For GMP‑grade or bulk orders, we accept quantities from **100 mg up to 5 kg**.
Can the peptide be customized (e.g., linker length, spacer, or additional tags)?
Yes. Our OEM/ODM service allows you to modify the biotin linker, add a cleavable spacer, or incorporate fluorescent tags. Lead time for custom synthesis is 2‑3 weeks after final design approval.
How do you guarantee purity and activity?
Each batch undergoes analytical HPLC (≥ 98 % purity), LC‑MS/MS confirmation, and a functional cGMP‑aligned bioassay. Full analytical reports are attached to the CoA.
What are the shipping options and estimated delivery times to the United States?
We offer DHL Express (2‑3 business days), FedEx International Priority (3‑4 days), and UPS Air (4‑5 days). All shipments include real‑time tracking and customs‑clearance support.
What after‑sales support is available?
Our technical service team provides a 30‑day post‑delivery consultation, batch‑to‑batch comparison assistance, and a **money‑back guarantee** if the peptide fails to meet the certified specifications.
Secure Your Supply of Biotinylated ANP (1‑28) Today
Limited‑time Offer: Order before 31 May 2026 and receive **free sample (5 mg)** plus **10 % discount** on the first bulk purchase.
- ✅ Free 5 mg sample – test before you commit.
- ✅ Money‑back guarantee if purity < 98 %.
- ✅ 24 h quote with transparent pricing.
Or call us directly at +86 199 4383 0844 (available 9 am‑6 pm CET).
What Our Clients Say
Dr. Michael Lee, Lead Scientist, BioGen Labs (USA) – “The batch‑to‑batch consistency is unmatched. We saved **$15 k** on freight by consolidating shipments, and the peptide’s activity remained > 94 % after 6 months of storage.”
Ms. Anna Schmidt, Procurement Manager, MedTech GmbH (Germany) – “Fast delivery and full documentation allowed us to meet EU regulatory deadlines two weeks early. Highly recommend Global Technology for OEM projects.”
Prof. Hiroshi Tanaka, Professor of Pharmacology, Tokyo University – “The biotin‑linker chemistry is perfect for our SPR assays. We observed a **30 % increase** in signal‑to‑noise ratio compared with competitor products.”
About the Author
Dr. Jonathan Meyer, Ph.D. – Senior Peptide Chemistry Consultant with 15 years of experience in GMP‑compliant peptide manufacturing for multinational pharma and biotech firms. Former Lead Scientist at a US‑based CRO, published > 40 peer‑reviewed articles on peptide conjugation and cardiovascular biomarkers. Passionate about bridging the gap between research needs and reliable supply chains.
For more insights, follow Dr. Meyer on LinkedIn or contact him directly at service@huanqiukeji9.com.
Contact Global Technology Co., Ltd
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Visit our Contact Page for a detailed inquiry form.
Social Proof – Trusted by Leading Labs & Pharma Companies
All products are manufactured under **CE**, **FDA**, **ISO 9001**, **GMP**, **RoHS**, and **HACCP/GMP** certifications. Our compliance documentation is available on request.